Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
national blog main
novartis
6
×
biotech
life sciences
national top stories
san francisco top stories
boston blog main
boston top stories
deals
national
new york top stories
roche
san francisco blog main
seattle blog main
seattle top stories
amgen
biogen
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
medicare
merck
new york blog main
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
cancer
diabetes
What
patients
6
×
bio
drug
roundup
digital
new
therapy
acquisitions
advantages
aims
albert
analytics
approved
atrophy
bar
becker
biggest
billions
biofourmis
bourla
brings
ceo
changes
company
crispr
daily
data
devices
diet
doctors
dollars
drugs
eaton
employs
evrysdi
exercise
expect
fda
friday
future
Language
unset
unknown
Current search:
novartis
×
photo
×
patients
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services